Synopsis
Synopsis
0
API Suppliers
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
API
0
FDF
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
EDQM
0
USP
0
JP
0
Others
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
1. Gk 11
2. Gk-11
3. Gk11
4. Methyl-2-r-(piperidine-1-)-1-(thienyl-2)1-cyclohexene
1. 68134-81-6
2. Gacyclidine [inn]
3. 1-[(1r,2s)-2-methyl-1-thiophen-2-ylcyclohexyl]piperidine
4. 1-(cis-2-methyl-1-(2-thienyl)cyclohexyl)piperidine
5. 9290nd070r
6. Gk-11
7. Nst-001
8. Unii-9290nd070r
9. Oto-311
10. (+)-gacyclidine
11. Methyl-2-r-(piperidine-1-)-1-(thienyl-2)1-cyclohexene
12. Gacyclidine [who-dd]
13. 1-[(1r,2s)-2-methyl-1-(thiophen-2-yl)cyclohexyl]piperidine
14. Schembl397836
15. Dtxsid30218313
16. Piperidine, 1-(2-methyl-1-(2-thienyl)cyclohexyl)-, Cis-
17. Zinc4213419
18. Akos016010755
19. Db13096
20. Q13560447
21. Piperidine, 1-((1r,2s)-2-methyl-1-(2-thienyl)cyclohexyl)-, Rel-
| Molecular Weight | 263.4 g/mol |
|---|---|
| Molecular Formula | C16H25NS |
| XLogP3 | 4.4 |
| Hydrogen Bond Donor Count | 0 |
| Hydrogen Bond Acceptor Count | 2 |
| Rotatable Bond Count | 2 |
| Exact Mass | 263.17077098 g/mol |
| Monoisotopic Mass | 263.17077098 g/mol |
| Topological Polar Surface Area | 31.5 Ų |
| Heavy Atom Count | 18 |
| Formal Charge | 0 |
| Complexity | 274 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 2 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 1 |
Neuroprotective Agents
Drugs intended to prevent damage to the brain or spinal cord from ischemia, stroke, convulsions, or trauma. Some must be administered before the event, but others may be effective for some time after. They act by a variety of mechanisms, but often directly or indirectly minimize the damage produced by endogenous excitatory amino acids. (See all compounds classified as Neuroprotective Agents.)
Excitatory Amino Acid Antagonists
Drugs that bind to but do not activate excitatory amino acid receptors, thereby blocking the actions of agonists. (See all compounds classified as Excitatory Amino Acid Antagonists.)
ABOUT THIS PAGE
A Gacyclidine manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Gacyclidine, including repackagers and relabelers. The FDA regulates Gacyclidine manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Gacyclidine API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A Gacyclidine supplier is an individual or a company that provides Gacyclidine active pharmaceutical ingredient (API) or Gacyclidine finished formulations upon request. The Gacyclidine suppliers may include Gacyclidine API manufacturers, exporters, distributors and traders.
Gacyclidine Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Gacyclidine GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Gacyclidine GMP manufacturer or Gacyclidine GMP API supplier for your needs.
A Gacyclidine CoA (Certificate of Analysis) is a formal document that attests to Gacyclidine's compliance with Gacyclidine specifications and serves as a tool for batch-level quality control.
Gacyclidine CoA mostly includes findings from lab analyses of a specific batch. For each Gacyclidine CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Gacyclidine may be tested according to a variety of international standards, such as European Pharmacopoeia (Gacyclidine EP), Gacyclidine JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Gacyclidine USP).
LOOKING FOR A SUPPLIER?
